Dubai PR Network, Online Press Release from Dubai and Middle East
 
Medicine, Laboratory & Treatment(Healthcare & Medicine)
Filter PR by
  
Julphar to Launch Wearable Insulin Delivery Device in GCC
 
Julphar to Launch Wearable Insulin Delivery Device in GCC
  • Exclusive distribution agreement signed with US medical technology company, Valeritas
  • ‘High-tech device will help empower diabetes sufferers to take control of their condition,’ says Julphar GM

December 12, 2018, Ras Al Khaimah (UAE) -   Julphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa, has signed an exclusive distribution agreement with medical technology company Valeritas Holdings, Inc. to bring its V-Go® Wearable Insulin Delivery device to the GCC.  

The device is an all-in-one, wearable insulin delivery option for patients with diabetes. Under the terms of the agreement, Julphar will have the rights to promote, market and sell the product to diabetes clinics and patients in the GCC. Julphar will be responsible for all sales, marketing, customer support and distribution activities in the region while Valeritas will retain responsibility for product development, regulatory approval, quality management and manufacturing.

Commenting on the announcement, Jerome Carle, General Manager of Julphar, said, “The prevalence of diabetes in the GCC is among the highest in the world. As a leader in the manufacture of insulin, Julphar has a responsibility to not only raise awareness of the risk factors but to provide effective solutions. 

“We are always exploring new, innovative and affordable options such as mobile tech, wearables and other tools, so partnering with Valeritas to bring the wearable V-Go® to the region made perfect sense. The high-tech device will help empower diabetes sufferers to take control of their condition and manage their own day-to-day care.”

With today’s announcement, Valeritas now has V-Go® distribution agreements in place covering 14 countries and territories. In addition to the Middle East countries, executed distribution agreements include Australia, Austria, the Czech Republic, Germany, Italy, Puerto Rico, Slovenia, and New Zealand.  Separately, Valeritas recently announced it has started the process to gain regulatory approval for V-Go® in China. 

John Timberlake, CEO and President of Valeritas, said: “Diabetes is now a worldwide epidemic. Currently, 425 million people suffer with diabetes, and that number is expected to grow to 629 million.

“For many patients with diabetes around the world, being able to adhere to a daily insulin routine of multiple injections using insulin pens and syringes is a significant challenge. Valeritas has consistently demonstrated in clinical studies that patients who switched from injection therapy to the wearable V-Go® significantly lowered blood glucose and used less insulin. 

“V-Go® is discrete, simple-to-use, cost-effective, clinically proven, and the only disposable, daily insulin delivery option available today. Partnering with Julphar, we are excited with the prospect of making V-Go® available to diabetes patients in the GCC.”  


Posted by : Dubai PR Network Editorial Team
Viewed 14176 times
PR Category : Healthcare & Medicine
Posted on : Wednesday, December 12, 2018  9:32:00 AM UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of DubaiPRNetwork.com.
Previous Story : RAK Hospitality Holding Signs MoU with Beit Al Khair Societ...
Next Story : Listen to the Autism Beat Gala Dinner at Atlantis - The Palm
Email this article Print this article

Share this article with your friends and followers
NewsVine
Back to Section Home

Related Stories



 
 
Most Viewed Press Release posted in the last 7 days
VARA - 2019 Fall/Winter Collection [8009-Views]
Nursery children gift Eid packages to labourers [5758-Views]
An increase of 36.7% compared to the first quarter [5216-Views]
Eid Al Adha Event Program [5081-Views]
US $859bn Oil, Gas and Petrochemical Projects Underway or Planned in the MENA Region as Gl... [5069-Views]
Dubai Festival City Mall Celebrates Global Independence Days with Exclusive IMAGINE shows [5039-Views]
Eid Gifting [4868-Views]
Turkish Airlines continues its journey to the top with new cabin uniforms [4673-Views]
Alisha Moopen appointed as the Deputy Managing Director of Aster DM Healthcare [4563-Views]
Evonik sticks to full-year outlook despite cooling economy [4490-Views]
Benefits to young people of becoming a freelancer a focus at International Youth Day event [4337-Views]
GEMS Education offers up some expert ways to get your children to read in the late summer ... [4240-Views]
Zulekha Hospital Sharjah Honored With Baby Friendly Hospital (BFHI) Accreditation From Uni... [4240-Views]
Al-Futtaim Toyota delivers strong H1 results [4148-Views]
FireEye Identifies Prolific Chinese Cyber Threat Group [4087-Views]
Eyes of the World on Expo 2020 Dubai [4056-Views]
MoHAP Announces Working Hours at Primary Health Care & Preventive Medicine Centers During ... [4038-Views]
Lenovo Introduces Single-socket Servers, Designed Specifically for Edge and Data-intensive... [3995-Views]
LG Signature Responds to Market Demand for Luxury Appliances With Expanded Lineup [3788-Views]
Show your Nanny some love and treat them to a Complimentary Haircut throughout August and ... [3654-Views]
9th Muslim World Business and Investment Zone to host Jewels of the Muslim World Award and... [3654-Views]
Sharjah Exports Development Center Achieves Record Results in First Half of 2019 [3599-Views]
Express Auto Wash offers festive deals during Eid Al Adha [3453-Views]
New Mimecast Report Reveals Analysis of 67 Billion Rejected Emails [3306-Views]
Introducing Lunette: A Tool to Empower Women [3306-Views]
 
RSS Facebook Twitter LinkedDin
 
Top Sections
 
Top Stories